1. Home
  2. NURO vs GTBP Comparison

NURO vs GTBP Comparison

Compare NURO & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NURO
  • GTBP
  • Stock Information
  • Founded
  • NURO 1996
  • GTBP 1965
  • Country
  • NURO United States
  • GTBP United States
  • Employees
  • NURO N/A
  • GTBP N/A
  • Industry
  • NURO Medical/Dental Instruments
  • GTBP Biotechnology: Pharmaceutical Preparations
  • Sector
  • NURO Health Care
  • GTBP Health Care
  • Exchange
  • NURO Nasdaq
  • GTBP Nasdaq
  • Market Cap
  • NURO 8.2M
  • GTBP 4.9M
  • IPO Year
  • NURO N/A
  • GTBP N/A
  • Fundamental
  • Price
  • NURO $4.41
  • GTBP $2.11
  • Analyst Decision
  • NURO
  • GTBP Strong Buy
  • Analyst Count
  • NURO 0
  • GTBP 1
  • Target Price
  • NURO N/A
  • GTBP $11.00
  • AVG Volume (30 Days)
  • NURO 19.3K
  • GTBP 29.6K
  • Earning Date
  • NURO 02-24-2025
  • GTBP 03-25-2025
  • Dividend Yield
  • NURO N/A
  • GTBP N/A
  • EPS Growth
  • NURO N/A
  • GTBP N/A
  • EPS
  • NURO N/A
  • GTBP N/A
  • Revenue
  • NURO $3,767,764.00
  • GTBP N/A
  • Revenue This Year
  • NURO N/A
  • GTBP N/A
  • Revenue Next Year
  • NURO N/A
  • GTBP N/A
  • P/E Ratio
  • NURO N/A
  • GTBP N/A
  • Revenue Growth
  • NURO N/A
  • GTBP N/A
  • 52 Week Low
  • NURO $2.66
  • GTBP $1.72
  • 52 Week High
  • NURO $4.73
  • GTBP $10.66
  • Technical
  • Relative Strength Index (RSI)
  • NURO 68.31
  • GTBP 42.40
  • Support Level
  • NURO $4.16
  • GTBP $2.03
  • Resistance Level
  • NURO $4.39
  • GTBP $2.29
  • Average True Range (ATR)
  • NURO 0.06
  • GTBP 0.19
  • MACD
  • NURO -0.00
  • GTBP 0.01
  • Stochastic Oscillator
  • NURO 85.58
  • GTBP 26.32

About NURO NeuroMetrix Inc.

NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.

Share on Social Networks: